Loading...
XSHG
603585
Market cap477mUSD
Dec 05, Last price  
18.07CNY
1D
1.75%
1Q
-2.59%
Jan 2017
-53.34%
IPO
-23.37%
Name

Suli Co Ltd

Chart & Performance

D1W1MN
XSHG:603585 chart
P/E
P/S
1.46
EPS
Div Yield, %
0.28%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
4.96%
Revenues
2.31b
+17.91%
679,434,117716,212,277813,425,696890,096,0471,122,807,6981,350,565,2501,456,615,0151,645,899,0471,812,605,5551,558,610,0292,291,648,7173,150,170,7521,958,208,4612,308,972,709
Net income
-11m
L
35,487,45360,076,74359,427,18668,806,432118,097,531185,256,877308,770,551426,176,161407,949,553174,747,119241,432,485315,328,47420,076,565-10,846,972
CFO
-42m
L
066,596,231165,419,165176,042,567147,068,573236,838,547284,550,206420,486,858486,332,393169,057,787316,004,317519,443,185216,380,552-41,724,481
Dividend
Jul 01, 20240.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Suli Co., Ltd. researches, produces, and sells agrochemicals, flame retardants, pharmaceutical intermediates, and other fine chemicals. The company offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane. It also provides brominated, environment-friendly, and halogen-free flame retardants; and intermediates, including trichloroacetonitrile, tetrachlorophthalonitrile, pentachloropyridine, pentachlorobenzonitrile, isophthalodinitrile, and hydrobromic acid, as well as 1,2-diphenylethane and 1,2-dibromoethane. In addition, the company offers industry biocides, such as Longee 985CHL, 550CCD, 550CC, and 500CHL; and ferric chloride solution for use in water treatment. It sells its products under the Suli brand name for use in agricultural production, and plastics and building materials industries, etc. in European Union, North America, South America, Africa, Southeast Asia, and other countries. Suli Co., Ltd. is based in Jiangyin, China.
IPO date
Dec 14, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT